|
市場調查報告書
美國的OAB市場
U.S. Overactive Bladder Market
|
美國的OAB市場 是由出版商Frost & Sullivan在2009年11月所出版的。
這份英文市場調查報告書包含83 Pages 價格從美金6000起跳。
報告內容包括:提供美國的OAB市場(2005∼2015年)相關調查、疾病的概要、產品分析、總市場收益預測、產品收益預測、提供患者數量預測及市場佔有率分析，產品區段別的分析、主要的市場課題、市場促進．阻礙因素等等統整。內容概要如下:
第1章 摘要
第2章 市場序論
- 調查範圍．調查手法
- 市場概要
- 市場工程學評價
- 疾病的概要
- 治療的選擇
- 業界的課題
- 市場促進因素
- 市場阻礙因素
- 產品分析
- 管道分析
第3章 競爭分析
- 概要
- 預測．動向
- 市場佔有率分析:
- 企業的市場佔有率
- 產品的市場佔有率
- 藥物輸送的市場佔有率
第4章 附錄
- 意思決定支援資料庫
- 65歳以上人口
- 65歳以上人口：女性
- 65歳以上人口：男性
- 整體出生時的平均壽命
- 出生率
Abstract
This research service covers the U.S. overactive bladder market from
2005-2015. Included is a disease overview, product analysis, total market
revenue forecasts, product revenue forecasts, patient forecasts and market
share analysis. The market is segmented by product: Detrol, Detrol LA,
Ditropan, Ditropan XL, Enablex, Oxytrol, Sanctura, Sanctura XR, VESIcare, and
others. Major market challenges, drivers, and restraints and identified and
discussed as well as pipeline by phase.
Table of Contents
1. Executive Summary
U.S. Overactive Bladder Market
2. Market Introduction
Research Scope and Methodology
- Scope and Segmentation
- Research Methodology
Market Overview
- Market Engineering Measurements
- Disease Overview
- Treatment Options
- Patient Forecasts
- Industry Challenges
- Market Drivers
- Market Restraints
Product Analysis
- Product Analysis
- Product Comparisons
- Recently Approved Products
Pipeline Analysis
- Phase III
- Phase II
- Phase I
3. Competitive Analysis
Overview
Forecasts and Trends
- Total Market
- Revenue Forecasts by Product
Market Share Analysis
- Company Market Share
- Product Market Share
- Drug Delivery Market Share
4. Appendix
Decision Support Databases
- Population 65 Plus
- Female Population 65 Plus
- Male Population 65 Plus
- Total Life Expectancy at Birth
- Birth Rate
|
